Physician
Waterbury Pulmonary Associates
Waterbury Pulmonary Associates was paid $1.02M by Medicaid between Jan 2018 and Nov 2021, across 27 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 32% of everything it billed.
33Billing provider infoWATERBURY PULMONARY ASSOCIATES
WATERBURY, CT 06708
WATERBURY, CT 06708
33aNPI1669501532assigned 03/05/2007
33bProvider typePulmonary Disease Physician
28Total paid$1.02M
24GClaims60,864
24DCodes billed27
24AFirst – last monthJan 2018 – Nov 2021
Compared with peers
Next to other Pulmonary Disease Physician providers in Connecticut
Rank by total paid#1 of 28
Median peer was paid$45K
This provider vs. median23×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 20,135 | $291K | |
| 2019 | 19,258 | $292K | |
| 2020 | 9,092 | $211K | |
| 2021 | 12,379 | $231K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 32% | 12,790 | 7,713 | $328K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 23% | 7,112 | 4,008 | $235K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 12% | 3,732 | 921 | $127K |
| 94010 | 9.8% | 15,569 | 9,325 | $101K | |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 9.8% | 8,043 | 2,556 | $101K |
| 94729 | 4.7% | 4,532 | 2,879 | $48K | |
| 94060 | 2.5% | 1,473 | 1,045 | $26K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.7% | 367 | 350 | $18K |
| 94726 | 1.6% | 1,022 | 735 | $16K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 553 | 366 | $10K |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 64 | 54 | $6K |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | <1% | 534 | 204 | $5K |
15 more codes
| 99442 | <1% | 141 | $2K | |
| 99223 | Prolong inpt eval add15 m | <1% | 81 | $853.20 |
| 99441 | <1% | 154 | $836.89 | |
| 99443 | <1% | 25 | $467.92 | |
| 90686 | <1% | 25 | $209.33 | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 61 | $186.28 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 97 | $105.12 |
| 99406 | <1% | 15 | $98.28 | |
| 94664 | <1% | 20 | $82.80 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 1,200 | $63.20 |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 804 | $57.04 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 440 | $14.44 |
| J2357 | Injection, omalizumab, 5 mg | 0% | 55 | $0.00 |
| 99058 | 0% | 19 | $0.00 | |
| 99072 | 0% | 1,936 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSILVERMAN, RICHARD (PHYSICIAN)